WO2009054360A1 - 内臓脂肪特異的低減剤 - Google Patents
内臓脂肪特異的低減剤 Download PDFInfo
- Publication number
- WO2009054360A1 WO2009054360A1 PCT/JP2008/069003 JP2008069003W WO2009054360A1 WO 2009054360 A1 WO2009054360 A1 WO 2009054360A1 JP 2008069003 W JP2008069003 W JP 2008069003W WO 2009054360 A1 WO2009054360 A1 WO 2009054360A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- agent
- visceral fat
- specifically reducing
- reducing visceral
- specifically
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
ヒト、特に肥満者の内臓脂肪特異的低減剤を提供する。本発明は、ヒスチジンまたはその塩を有効成分として含有する、ヒト、特に肥満者に対する内臓脂肪特異的低減剤を提供する。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009538208A JPWO2009054360A1 (ja) | 2007-10-22 | 2008-10-21 | 内臓脂肪特異的低減剤 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007274146 | 2007-10-22 | ||
JP2007-274146 | 2007-10-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2009054360A1 true WO2009054360A1 (ja) | 2009-04-30 |
Family
ID=40579465
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2008/069003 WO2009054360A1 (ja) | 2007-10-22 | 2008-10-21 | 内臓脂肪特異的低減剤 |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPWO2009054360A1 (ja) |
WO (1) | WO2009054360A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015053337A1 (ja) * | 2013-10-09 | 2015-04-16 | 味の素株式会社 | ヒスチジンを含有する食品およびその用途 |
WO2018181619A1 (ja) * | 2017-03-28 | 2018-10-04 | 味の素株式会社 | 腸内環境改善用食品 |
-
2008
- 2008-10-21 WO PCT/JP2008/069003 patent/WO2009054360A1/ja active Application Filing
- 2008-10-21 JP JP2009538208A patent/JPWO2009054360A1/ja active Pending
Non-Patent Citations (2)
Title |
---|
SAKATA T. ET AL.: "Clinical implications of histamine neurons activation driven by mastication and L-histidine: an efficient therapeutic approach to visceral fat reduction and weight loss", THE JAPANESE JOURNAL OF TASTE AND SMELL RESEARCH, vol. 13, no. 3, pages 271 - 276 * |
SAKATA T.: "Naizo Shibo Sakugen o Mezashita Himansho Chiryo no Aratanaru Tenkai", JOURNAL OF JAPAN SOCIETY FOR THE STUDY OF OBESITY, vol. 12, 30 September 2006 (2006-09-30), pages 103 * |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015053337A1 (ja) * | 2013-10-09 | 2015-04-16 | 味の素株式会社 | ヒスチジンを含有する食品およびその用途 |
CN105592725A (zh) * | 2013-10-09 | 2016-05-18 | 味之素株式会社 | 含有组氨酸的食品及其应用 |
JPWO2015053337A1 (ja) * | 2013-10-09 | 2017-03-09 | 味の素株式会社 | ヒスチジンを含有する食品およびその用途 |
EP3066937A4 (en) * | 2013-10-09 | 2017-11-01 | Ajinomoto Co., Inc. | Foodstuff containing histidine and application therefor |
US10390553B2 (en) | 2013-10-09 | 2019-08-27 | Ajinomoto Co., Inc. | Food containing histidine and use thereof |
WO2018181619A1 (ja) * | 2017-03-28 | 2018-10-04 | 味の素株式会社 | 腸内環境改善用食品 |
WO2018181621A1 (ja) * | 2017-03-28 | 2018-10-04 | 味の素株式会社 | 腸内環境改善用飼料組成物 |
EP3603421A4 (en) * | 2017-03-28 | 2021-02-17 | Ajinomoto Co., Inc. | FEED COMPOSITION TO IMPROVE THE INTRAINTESTINAL ENVIRONMENT |
EP3603420A4 (en) * | 2017-03-28 | 2021-04-14 | Ajinomoto Co., Inc. | FOOD TO IMPROVE THE INTRAINTESTINAL ENVIRONMENT |
US11376215B2 (en) | 2017-03-28 | 2022-07-05 | Ajinomoto Co., Inc. | Feed composition for improving intraintestinal environment |
US11426347B2 (en) | 2017-03-28 | 2022-08-30 | Ajinomoto Co., Inc. | Food for improving intraintestinal environment |
Also Published As
Publication number | Publication date |
---|---|
JPWO2009054360A1 (ja) | 2011-03-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200902632B (en) | Haloalkylsufonanilide derivative or salt thereof, herbicide comprising the derivative as active ingredient, and use of the herbicide | |
TWI366469B (en) | Emulsified skin agent for external use | |
EP1895950A4 (en) | IN HUMAN IMPLANTABLE TISSUE EXPANDERS | |
ZA200708692B (en) | Nanoparticle/active ingredient conjugate | |
HK1166263A1 (en) | Use of a foamable composition essentially free of pharmaceutically active ingredients for the treatment of human skin | |
ZA200702960B (en) | Fungicidal active ingredient combinations containing fluoxastrobin | |
ZA200709999B (en) | Fungicidal active ingredient combination | |
IL177061A0 (en) | Antimicrobial tissue products with reduced skin irritation potential | |
EP2394986A4 (en) | DERIVATIVES OF 3 AMINOXALYLAMINOBENZAMIDE AND INSECTICIDE AND MITICIDE AGENTS CONTAINING SAME AS ACTIVE INGREDIENT | |
IL196578A0 (en) | Aqueous active ingredient concentrate having an herbicidal effect | |
WO2009041663A1 (ja) | 皮膚疾患の予防及び/または治療剤 | |
EP2196206B8 (en) | Remedy for relieving skin troubles comprising morphinan derivative or pharmacologically acceptable acid addition salt thereof as the active ingredient | |
PL2306816T3 (pl) | Zastosowanie miejscowych kompozycji do konserwowania ludzkiego lub zwierzęcego ciała | |
EP2166015A4 (en) | LINCOSAMIDE DERIVATIVE AND ANTIBACTERIAL AGENT CONTAINING ACTIVE SUBSTANCE | |
PL1956913T3 (pl) | Grzybobójcza kombinacja substancji czynnej | |
WO2009103959A3 (en) | Histidine and/or histidine derivative for the treatment of inflammatory skin diseases | |
HK1158926A1 (en) | Gentle, non-irritating, non-alcohoholic skin disinfectant | |
WO2009054360A1 (ja) | 内臓脂肪特異的低減剤 | |
EP1967208A4 (en) | THERAPEUTIC AGENT FOR SKIN OR AGENT PROMOTING REGENERATION OF SKIN CONTAINING GHRELINE, AND DERIVATIVES THEREOF OR SUBSTANCE CAPABLE OF ACTING AS ACTIVE INGREDIENT ON GHS-R1a | |
WO2011026577A3 (de) | Zubereitungen mit wasserunlöslichen polymeren aminen zur verminderung von körpergeruch | |
EP1967201A4 (en) | THERAPEUTIC AGENT FOR SKIN OR SKIN REGENERATING AGENT CONTAINING DESACYL-GHRELINE OR A DERIVATIVE THEREOF AS ACTIVE INGREDIENT | |
WO2008143280A1 (ja) | 鎮静剤 | |
WO2005082336A3 (de) | Kit aus einem gegebenenfalls wirkstoffhaltigen pflaster und einem hautirritationen verhindernden mittel | |
PL2119700T3 (pl) | Pochodna benzyloaminy lub jej farmaceutycznie dopuszczalna sól addycyjna z kwasem oraz ich zastosowanie do celów medycznych | |
TJ405B (en) | Preparation vitagin for treatment of endometritis of cows. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08841404 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2009538208 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08841404 Country of ref document: EP Kind code of ref document: A1 |